OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
MRSH$169.1559

Marsh & McLennan Companies Inc

Multiline Insurance & BrokersVerified

Marsh & McLennan Companies Inc (MRSH.K) maintains a market price of $169.15, with a market capitalization of $81.5 billion, and a price-to-earnings ratio of 72.44, which is significantly higher than the industry median. The company's liquidity position is characterized by a current ratio of 1.17 and a negative net cash position after subtracting total debt, indicating a medium liquidity risk. The price-to-book ratio of 6.1 suggests that the company is trading at a premium to its book value, which may reflect investor expectations of future earnings growth. In terms of profitability, the company's return on equity (ROE) is 8.42%, and its return on assets (ROA) is 2.32%. These figures are below the industry median for ROE and ROA, indicating that the company is underperforming its peers in terms of capital efficiency and asset utilization. The company's operating margin is 26.4%, and its net margin is 18.1%, which are both in line with the industry median, suggesting that the company is maintaining its profitability relative to its peers. The company's revenue is primarily derived from its global operations, with a significant portion coming from North America. The company's exposure to North America is a key factor in its revenue concentration, and any economic downturn in this region could have a material impact on its financial performance. The company's geographic diversification is limited, with a high concentration of revenue in a single region, which increases its vulnerability to regional economic fluctuations. Looking at the company's growth trajectory, the current fiscal year is expected to show a revenue increase of 4.5%, and the next fiscal year is projected to see a revenue increase of 3.2%. These growth rates are in line with the industry median, indicating that the company is maintaining a steady pace of growth relative to its peers. The company's capital expenditure is negative, suggesting that it is not investing in new assets, which may indicate a focus on cost control and operational efficiency. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt highlights the company's liquidity constraints. The company's debt-to-equity ratio is 1.01, which is slightly above the industry median, indicating a moderate level of leverage. The company's free cash flow of $884 million provides some flexibility in managing its debt obligations and funding operations. Recent events, including analyst estimates and price targets, suggest a generally positive outlook for the company. The mean price target of $204.00 and the median price target of $200.00 indicate that analysts expect the stock to appreciate in value. The mean recommendation of 2.71, with a strong-buy count of 1 and a buy count of 6, suggests that the majority of analysts have a positive view of the company's prospects. The hold count of 16 indicates a more cautious stance from some analysts, but the overall sentiment remains positive.

30-day price · MRSH-13.77 (-7.9%)
Low$158.16High$183.45Close$161.05As of17 May, 00:00 UTC
Profile
CompanyMarsh & McLennan Companies Inc
TickerMRSH.K
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryMultiline Insurance & Brokers
AI analysis

Business. Marsh & McLennan Companies Inc provides risk, insurance, and investment products and services to clients globally, generating revenue primarily through commissions, fees, and investment income.

Classification. The company is classified under the Financials economic sector, Insurance business sector, and Multiline Insurance & Brokers industry with a confidence level of 0.92.

Marsh & McLennan Companies Inc (MRSH.K) maintains a market price of $169.15, with a market capitalization of $81.5 billion, and a price-to-earnings ratio of 72.44, which is significantly higher than the industry median. The company's liquidity position is characterized by a current ratio of 1.17 and a negative net cash position after subtracting total debt, indicating a medium liquidity risk. The price-to-book ratio of 6.1 suggests that the company is trading at a premium to its book value, which may reflect investor expectations of future earnings growth. In terms of profitability, the company's return on equity (ROE) is 8.42%, and its return on assets (ROA) is 2.32%. These figures are below the industry median for ROE and ROA, indicating that the company is underperforming its peers in terms of capital efficiency and asset utilization. The company's operating margin is 26.4%, and its net margin is 18.1%, which are both in line with the industry median, suggesting that the company is maintaining its profitability relative to its peers. The company's revenue is primarily derived from its global operations, with a significant portion coming from North America. The company's exposure to North America is a key factor in its revenue concentration, and any economic downturn in this region could have a material impact on its financial performance. The company's geographic diversification is limited, with a high concentration of revenue in a single region, which increases its vulnerability to regional economic fluctuations. Looking at the company's growth trajectory, the current fiscal year is expected to show a revenue increase of 4.5%, and the next fiscal year is projected to see a revenue increase of 3.2%. These growth rates are in line with the industry median, indicating that the company is maintaining a steady pace of growth relative to its peers. The company's capital expenditure is negative, suggesting that it is not investing in new assets, which may indicate a focus on cost control and operational efficiency. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt highlights the company's liquidity constraints. The company's debt-to-equity ratio is 1.01, which is slightly above the industry median, indicating a moderate level of leverage. The company's free cash flow of $884 million provides some flexibility in managing its debt obligations and funding operations. Recent events, including analyst estimates and price targets, suggest a generally positive outlook for the company. The mean price target of $204.00 and the median price target of $200.00 indicate that analysts expect the stock to appreciate in value. The mean recommendation of 2.71, with a strong-buy count of 1 and a buy count of 6, suggests that the majority of analysts have a positive view of the company's prospects. The hold count of 16 indicates a more cautious stance from some analysts, but the overall sentiment remains positive.
Key takeaways
  • Marsh & McLennan Companies Inc is trading at a premium to book value, with a price-to-book ratio of 6.1.
  • The company's return on equity (8.42%) and return on assets (2.32%) are below the industry median, indicating underperformance in capital efficiency.
  • The company's revenue is heavily concentrated in North America, increasing its vulnerability to regional economic fluctuations.
  • Analysts have a generally positive outlook, with a mean price target of $204.00 and a mean recommendation of 2.71.
  • The company's liquidity position is characterized by a current ratio of 1.17 and a negative net cash position after subtracting total debt.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$6.22B
Gross profit
Operating income$1.64B
Net income$1.12B
R&D
SG&A
D&A
SBC
Operating cash flow$434.0M
CapEx-$167.0M
Free cash flow$884.0M
Total assets$48.59B
Total liabilities$35.22B
Total equity$13.37B
Cash & equivalents$1.65B
Long-term debt$13.54B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$19.82B$4.31B$3.14B$2.49B
FY-3$20.72B$4.28B$3.05B$2.20B
FY-2$22.74B$5.28B$3.76B$2.78B
FY-1$24.46B$5.82B$4.06B$3.03B
FY0$26.98B$6.22B$4.16B$3.15B
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$34.39B$11.01B$1.75B
FY-3$44.11B$10.52B$1.44B
FY-2$48.03B$12.19B$3.36B
FY-1$56.48B$13.34B$2.40B
FY0$58.71B$15.10B$2.69B
PeriodOCFCapExFCFSBC
FY-4$3.52B-$406.0M$2.49B
FY-3$3.46B-$470.0M$2.20B
FY-2$4.26B-$433.0M$2.78B
FY-1$4.30B-$316.0M$3.03B
FY0$5.29B-$291.0M$3.15B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$6.22B$1.64B$1.12B$884.0M
FQ-6$5.70B$1.11B$747.0M$455.0M
FQ-5$6.07B$1.14B$788.0M$523.0M
FQ-4$7.06B$2.00B$1.38B$1.18B
FQ-3$6.97B$1.83B$1.21B$998.0M
FQ-2$6.35B$1.17B$747.0M$464.0M
FQ-1$6.59B$1.22B$821.0M$513.0M
FQ0$7.60B$1.75B$1.15B$911.0M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$48.59B$13.37B$1.65B
FQ-6$49.86B$13.69B$1.80B
FQ-5$56.48B$13.34B$2.40B
FQ-4$57.02B$14.06B$1.60B
FQ-3$58.55B$15.77B$1.68B
FQ-2$58.78B$15.15B$2.51B
FQ-1$58.71B$15.10B$2.69B
FQ0$58.55B$14.57B$1.61B
PeriodOCFCapExFCFSBC
FQ-7$434.0M-$167.0M$884.0M
FQ-6$2.35B-$240.0M$455.0M
FQ-5$4.30B-$316.0M$523.0M
FQ-4-$622.0M-$55.0M$1.18B
FQ-3$1.05B-$114.0M$998.0M
FQ-2$3.13B-$186.0M$464.0M
FQ-1$5.29B-$291.0M$513.0M
FQ0-$688.0M-$62.0M$911.0M
Valuation
Market price$169.15
Market cap$81.50B
Enterprise value$93.39B
P/E72.4
Reported non-GAAP P/E
EV/Revenue15.0
EV/Op income56.9
EV/OCF215.2
P/B6.1
P/Tangible book6.1
Tangible book$13.37B
Net cash-$11.89B
Current ratio1.2
Debt/Equity1.0
ROA2.3%
ROE8.4%
Cash conversion39.0%
CapEx/Revenue-2.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Asset Management · cohort 27 companies
MetricMRSHActivity
Op margin26.4%10.7% medp25 0.3% · p75 28.3%above median
Net margin18.1%6.3% medp25 -0.8% · p75 18.8%above median
Gross margin47.8% medp25 32.7% · p75 78.3%
CapEx / revenue-2.7%-2.6% medp25 -5.5% · p75 -0.8%below median
Debt / equity101.0%4.4% medp25 0.0% · p75 36.0%top quartile
Observations
IR observations
Mean price target204.00 USD
Median price target200.00 USD
High price target236.00 USD
Low price target179.00 USD
Mean recommendation2.71 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count6.00
Hold count16.00
Sell count1.00
Strong-sell count0.00
Mean EPS estimate10.39 USD
Last actual EPS9.75 USD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-01 04:01 UTC#5fb2b61a
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 15:43 UTCJob: a48593d8